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Abstract—Smart hydrogels for biomedical applications are 
highly researched materials. However, integrating them into a 
device for implantation is difficult. This paper investigates an 
integrated delivery device designed to deliver an electro-
responsive hydrogel to a target location inside a blood vessel with 
the purpose of creating an occlusion. The paper describes the 
synthesis and characterization of a Pluronic/methacrylic acid 
sodium salt electro-responsive hydrogel. Application of an 
electrical bias decelerates the expansion of the hydrogel. An 
integrated delivery system was manufactured to deliver the 
hydrogel to the target location in the body. Ex vivo and in vivo 
experiments in the carotid artery of sheep were used to validate 
the concept. The hydrogel was able to completely occlude the 
blood vessel reducing the blood flow from 245 ml/min to 0 ml/min 
after implantation. Ex vivo experiments showed that the hydrogel 
was able to withstand physiological blood pressures of > 270 
mmHg without dislodgement. The results showed that the 
electro-responsive hydrogel used in this paper can be used to 
create a long-term occlusion in a blood vessel without any 
apparent side effects. The delivery system developed is a 
promising device for the delivery of electro-responsive hydrogels. 
 
Index Terms— Blood Vessel, Cardiovasular, Delivery Device, 
Electroactivation, Hydrogel, Occlusion.  
I. INTRODUCTION 
During the last two decades there have been significant 
advances in the development of smart hydrogels for 
biomedical applications [1-3]. Hydrogels are ideal for 
biomedical applications due to their ability to swell/deswell 
several thousand times their original volume. Smart hydrogels 
have the capability of changing their dimensions due to an 
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external stimulus, which can include thermal, magnetic, light, 
electrical, or pH [4, 5]. However, with the exception of 
electrical stimulus these methods are less suitable for 
implantable biomedical applications as they are difficult to 
integrate into a medical device. Although there have been 
significant advances in the development of smart hydrogels, 
integrating them onto an implantable system has been limited 
[6].   
 The most commonly used biomedical applications for smart 
hydrogels are artificial muscles [7] or drug delivery [8], where 
an applied stimulus causes the hydrogel to expand or deswell 
which releases a specified volume of drug. Another 
application which is currently being investigated uses the 
hydrogel’s ability to expand significantly in order to create an 
occlusion in a blood vessel [9]. Smart hydrogels have 
previously been used as valves in fluidic devices [10]. 
Previously, non-stimuli responsive hydrogels have been used 
to embolize blood vessels in aneurysms.  In these cases the 
hydrogel can be coated on a coil [11] or they can be injected at 
the site of the aneurysm [12].  
There are several medical procedures which require the 
occlusion of blood vessels including a blood vessel wall bleed, 
vascular embolization, aneurysms, and prevention of blood 
from reaching a particular location, such as in cancer 
therapy[13, 14]. Currently, the treatment for these conditions 
includes invasive surgical repair or cauterizing the blood 
vessel [15].   
 Due to their swelling capacity in aqueous solutions, 
hydrogels are ideal for creating occlusions in blood vessels 
because they can be introduced to the vascular system in a 
compact state and expand significantly in blood. However, 
once the hydrogel is in contact with the blood it begins to 
swell immediately, making delivery of the hydrogel to the 
target location in a timely manner critical. Surgical procedures 
which involve implantation of a hydrogel can vary in time 
duration depending on the target location. In the case where an 
implantation takes several minutes a typical hydrogel could 
expand and occlude an unwanted blood vessel which has 
potential to cause fatal side effects. An increased delivery time 
could be required due to tortousity or stenosis in the blood 
vessel. Alternatively, a smart hydrogel can be used to reduce 
the risk of unsuccessful delivery of the hydrogel by 
decelerating expansion through an applied stimulus.  
The stimulus investigated in this paper includes an electrical 
bias that can be applied to the hydrogel while it is being 
delivered. Electrical stimuli have previously been shown to 
actuate electro-responsive hydrogels (ERH) for applications 
including artificial muscles[16]. ERH applications typically 
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include bending of the material in salt solutions. The ERH 
bends while between two sheet electrodes of opposite 
potential [17]. Recently it has been shown that an 
interdigitated (IDT) electrode array can be used to create a 
uniform cylindrical deswelling [9]. Therefore, the possibility 
of slowing down the expansion of a cylindrical ERH during 
implantation is feasible. This paper investigates the use of an 
ERH to create an occlusion in a blood vessel. However, there 
are several key challenges which will also need to be 
addressed including i) the ERH ability  to expand and adhere 
to the blood vessel surface creating an occlusion under normal 
physiological blood pressures and, ii) the development of a 
delivery device that can be used for short or long duration 
implants. 
 This paper aims to develop a system to deliver a smart 
hydrogel to the target location with a minimally invasive 
procedure in order to occlude a blood vessel.  This requires 
integration of various components including:  a specifically 
modified Pluronics ERH, a flexible IDT electrode device to 
apply the electrical bias, and a manufactured delivery device 
to deliver the ERH through the blood vessels. Figure 1 shows 
the application concept that is investigated within this paper. 
The schematic shows a blood vessel bleed for visual purposes 
as the concept could be applied to numerous occlusion 
applications.  
 This paper deals with design and manufacturing of a 
delivery device with integrated flexible IDT electrodes that is 
capable of successfully delivering an ERH to a target location 
in vivo. A proof of concept of the application is demonstrated 
through in vitro electrical and mechanical characterization of 
the ERH, followed by a study on the capability of the ERH to 
occlude a carotid artery in both ex vivo and in vivo using the 
integrated delivery device. The development of an integrated 
delivery device and its operation is described below. 
 
Fig. 1.  Schematic of the application and integrated delivery device with 
interdigitated electrodes to prevent swelling of the hydrogel. (a) application 
involving a bleeding of a blood vessel (b) delivery of electro-responsive 
hydrogel where the electrical bias prevents swelling (c) remove electrical bias 
and release device at the target location allowing hydrogel to passively swell 
(d) zoomed in image of the electrode configuration with unswollen ERH in 
the center. 
II. MATERIALS AND METHODS 
A. Synthesis of Electro-Responsive Hydrogels 
The ERH used in this study is a Pluronic/methacrylic acid 
sodium salt hydrogel (PLMANa). Pluronic F127, an ABA 
block copolymer, was chosen as a base material because of its 
known biocompatibility. The ERH was prepared by 
crosslinking methacrylate endcapped Pluronic F127 (PF127-
BMA) with the sodium salt of methacrylic acid, as described 
previously [18]. Briefly, 1.5 g of PF127-BMA (PL), 2.4 g of 
hydrolyzed methacrylic acid sodium salt (MANa), and 4.6 g of 
deionized water (DI) (with resistivity of 18 MΩ cm) were 
mixed together. A 1 M ammonium persulfate (APS) (Sigma 
Aldrich A3678) solution (0.75 ml) was added as the initiator, 
and a 1 M tetramethylethylenediamine (TEMED) (Sigma 
Aldrich T9281) solution (0.75 ml) as the accelerator. The 
solution was slowly mixed, covered with a blanket of N2 gas 
to avoid oxygen trapping, and then transferred to a mold and 
refrigerated for 1 hour before being transferred to a water bath 
at 37°C for 3 hours. The molds consisted of various sized 
silicone tubes in order to create a cylindrical shape.  
After polymerization was completed the samples were 
removed from the molds and purified in Krebs solution for 3 
days to remove any residual material. After purification the 
samples were air dried to deswell the hydrogels to the 
appropriate dimensions. The dried hydrogel samples were then 
used for in vitro characterization or they were integrated on 
the delivery device for ex vivo and in vivo implantation trials.  
B. Swelling Characterization  
The rate of swelling and the maximum swelling of the 
hydrogels are critical for this application. To characterize the 
ERH, dried hydrogels samples with a diameter of 2.5 mm and 
lengths of 4 mm were prepared. Samples (n=3) were placed 
into two different solutions to determine the swelling rate in 
different ionic concentrated solutions. The samples were 
submersed in Krebs solution (a blood mimicking solution), 
and blood plasma for 24 hours. The swelling rate is expected 
to be similar in blood plasma and Krebs because they both 
have similar ionic concentrations and previous results have 
shown that the electroactuation of ERH is similar for both 
solutions [18]. Swelling was determined by weighing the dried 
samples (Wd) and the swollen samples (Ws) using the 
following formula. 
%100*
d
ds
W
WW
S
−
=                     (1) 
C. Electroactuation of Hydrogels 
Electro-responsivity of the PLMANa material using sheet 
electrodes for bending tests were previously published [19]. 
However, to produce radial deswelling, which is required for 
this application, a 3-D macro-scale interdigitated (IDT) 
electrode device was developed. The 3-D IDT electrode was 
used to validate the concept that an electrical bias can 
decelerate expansion while the hydrogel is being delivered in 
the body. The IDT electrode configuration creates a uniform 
electric field, allowing the hydrogel to expand/deswell 
radially. The IDT electrode device was previously validated 
[9]. The device consists of 500 µm diameter Pt electrodes that 
are equally spaced every 45°. The electrodes alternate between 
cathode and anode, and the hydrogel is situated in the center. 
In order to validate the concept in an in vitro experiment the 
hydrogels were purified in DI water following synthesis, in 
order to reduce the number of ions in the ERH. After 
purification, the samples were air-dried until deswelling had 
ceased. Two sets of hydrogels (n=3) were used in the 
experiment, i) controlled (non-electro biased) and ii) electro-
biased sample. The dried hydrogels had a diameter of 3 mm, 
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due to the size of the macroscale electrodes. After the samples 
were dried they were placed in the IDT electrode device in a 
Krebs solution environment. The electrically biased samples 
were biased using previously reported parameters [20], which 
consisted of a pulsed DC (monophasic) waveform with 5 Vpp, 
50% Duty Cycle at 1 kHz. The hydrogels were removed from 
the experimental setup and weighed periodically throughout 
the experiment. Swelling was determined based on (1). 
D. Fabrication of flexible microelectrodes 
Flexible micro-electrodes were required in order to integrate 
the IDT electrode design into a delivery device. The micro-
electrodes were fabricated on a glass substrate for mechanical 
support as shown in Fig 2a. Polyimide pre-cursor (PI-2611, 
HD Microsystems) was spin-coated and then imidized in a 
nitrogen oven  at 350ºC resulting in a uniform 5 µm thick 
polyimide layer [21, 22]. Polyimide was chosen as the flexible 
substrate because of its biocompatibility and favorable 
processing properties and low water adsorption. [23, 24]. 
Following imidization, the surface of the film was micro-
roughened to increase adhesion to the subsequently deposited 
metal layer. A metallization stack consisting of 50 nm 
titanium (Ti) adhesion layer and a 200 nm gold layer was 
sputter deposited. Using standard photo-lithography and wet 
etching techniques, this metal stack was then patterned to form 
the IDT electrode configuration, the bond pads and the 
interconnection. On top of this a 100 nm TiW metal layer was 
deposited. The TiW layer was added as a barrier layer to 
protect the Au from dissolution at higher voltages (>1 V) in 
ionic concentrated solution. A 30 nm Pt layer was then 
deposited using electron beam evaporation and patterned using 
a lift-off technique. The Pt was used as the electrode material 
due to its chemical stability under an electrical bias in a salt 
solution [25]. A second polyimide layer (5 µm thick) was 
applied and imidized, and acted as an insulation layer between 
the electrodes. Reactive ion etching was used to etch through 
the polyimide layer, in order to open up the electrodes, bond 
pads and to define the shape of the flexible microelectrode 
device. The devices were mechanically removed from the 
glass substrate.  
 
Fig. 2. (a) Schematic of the fabrication process for the micro-electrodes. Top 
to bottom: glass carrier with first polyimide layer – Ti/Au metallization – 
additional TiW metallization for the electrodes – Pt metallization for the 
electrodes – second polyimide layer – opening of electrode and bondpad areas 
– release from carrier. (b) Picture of flexible micro-fabricated IDT electrodes 
 
Pure Pt electrodes would be the ideal material for the 
electrodes. However, for reasons such as cost, 
manufacturability and connectivity, a Pt only metallization is 
not feasible. Therefore Au was chosen as the core metal, with 
a thin Pt coating on top. Gold can be easily dissolved under an 
electrical bias in a chloride-rich electrolyte, so an additional 
protection layer of TiW was deposited. 
The flexible IDT electrode device was fabricated so that it 
could be attached to the inner wall of a catheter. The IDT 
design consists of six electrodes that are 800 µm wide with 
400 µm pitch and 15 mm in length as shown in Fig. 2b. 
E. Delivery Device 
The delivery device is a critical component to the system, as 
the ERH requires an integrated tool for transporting the 
material to the target location and applying an electrical bias 
to the material during transportation.  The delivery device also 
must contain a method of holding the ERH during delivery, 
pushing the ERH out of the catheter, and a method for 
releasing it after it is swollen. 
The basic concept of the device is to contain a holder, 
which can hold the dried hydrogel prior to expansion, a 
catheter to protect the hydrogel during delivery, a flexible IDT 
electrodes inside the catheter, a mechanical pusher to extend 
the hydrogel out of the catheter, a conical balloon at the 
proximal end of the ERH to temporarily block the blood flow, 
and a method to release the holder. Figure 3 shows the 
schematic design and the manufactured device (Aran Research 
and Development, Israel). The delivery device consists of a 9 
FR sheath that is pre-inserted into the target location and a 7 
FR catheter containing the holder, the IDT flexible electrodes, 
and the ERH. The holder is a stainless steel wire of 0.9mm 
which partially penetrates the ERH. The ERH can be molded 
to contain a 0.9mm hole in the middle. A through-hole guide 
wire was not used because a hole extending through the entire 
length of the ERH would prevent a full occlusion by allowing 
residual blood flow through the ERH. Figure 3d shows the 
dried hydrogel mounted on the holder. The flexible IDT 
electrodes were bonded to the inside of the catheter using UV 
curable biocompatible non-conducting epoxy (Loctite 3341). 
The IDT electrodes are connected to electrical wires that 
extend back to the handle where they can be connected to a 
signal generator as shown in Fig. 3c. Figure 3e shows a 
micrograph of the tip of the catheter with ERH and IDT 
electrodes. The balloon can be used to prevent blood flow 
when the flow is going in the direction of the insertion, this 
helps prevent the risk of the hydrogel being released 
prematurely from the holder. However, in cases where the 
blood flow is against the insertion such a balloon is not 
necessary. The handle contains ports for the catheter, sheath 
and balloon; it also contains a mechanical pusher that extends 
the ERH from the catheter and into the environment. Figure 3d 
shows the extended ERH before it is loaded into the catheter 
and Fig. 3e shows the tip of the hydrogel as it is pushed out of 
the catheter.  
The operational procedure for the delivery of the hydrogel 
begins with inserting the sheath to the desired location. Next, 
the dried hydrogel is mounted on the holder and retracted into 
the catheter which is then inserted into the device through the 
handle. The electrical bias can then be applied via a signal 
generator if the procedure is likely to take several minutes. 
The electrical bias is required to prevent swelling, because the 
ERH starts to swell when it comes into contact with fluid, and 
if the ERH swells while inside the catheter the pusher will not 
be able to deploy the ERH out of the catheter without the risk 
of damaging the ERH. Once the tip of the catheter is at the 
target location the hydrogel is extended out of the catheter, the 
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balloon is inflated, the electrical bias is switched off, and 
expansion is started. The holder remains in place until the 
ERH expands to the blood vessel wall, which can be assessed 
by using a light push/pull movement, then the holder is 
retracted into the catheter and the delivery device is removed, 
leaving behind the hydrogel to occlude the blood vessel. The 
occlusion of the blood vessel can also be monitored via 
angiography or fluoroscopy. 
 
Fig. 3. Schematics and images of the ERH delivery device a) schematic of the 
handle for the delivery device which contains a pusher and rotator, an 
electrical connection for the electrodes, a saline/dye supply port and balloon 
inflation port. B) Schematic of the distal end of the delivery device containing 
the dry hydrogel, flexible IDT electrodes, holding bar, and pusher. C) Photo of 
the manufactured delivery device handle with electrical connection. D) Photo 
of hydrogel on the delivery device before it is loaded and the inflated balloon. 
E) Micrograph of the IDT electrode and hydrogel as it is being pushed out of 
the sheath. Scale bar is 2mm. 
F. Ex Vivo Concept Testing 
Prior to in vivo testing the authors performed ex vivo 
occlusion experiments to determine if the ERH could create an 
occlusion in an extracted carotid artery. The carotid artery of a 
sheep was mounted in a custom built circulatory system with 
Krebs solution being pumped through it. The carotid artery 
was placed in a tissue bath with Krebs solution to minimize 
the effect of altering the mechanical elasticity due to air. The 
circulatory system allowed the researchers to increase the 
pressure and monitor the maximum pressure needed to move 
the ERH after it was swollen.  
Dried ERH of 3.9 mm diameter (n=3) were used in this 
experiment due to the size of the arteries. The hydrogels were 
held in place with a catheter until they were fully swollen then 
the catheter was removed. Pressure in the circulatory system 
was increased until movement of the ERH was visually seen. 
This experiment was used to validate the capability of the 
ERH to occlude the blood vessel, and to show that the ERH 
could withstand physiological blood pressures. If the ERH 
could not withstand blood pressure, the hydrogel would 
become dislodged and could create an emboli.  
G. In Vivo Testing 
 In vivo testing of the occlusion capabilities of the ERH was 
performed in an adult sheep. The hydrogel samples were 
sterilized using ethylene oxide. All procedures were carried 
out with the approval of the ethical committee for animal 
experiments at KU Leuven, Belgium. The sheep (n=4) were 
sedated with an intramuscular injection of ketamine (15 
mg/kg). Anesthesia was induced with isoflurane 5% (Isoba, 
Scherin-Plough, Brussels), and the animal was intubated with 
an oral-gastric tube. Anesthesia was maintained with 
isoflurane (2-4%). Arterial lines were inserted in the ears, 
while heart rate, blood pressure, CO2 and blood O2 were 
monitored. The hydrogel was implanted in the right carotid 
artery and pressure measurements were monitored distal and 
proximal to the hydrogel to validate occlusion using an intra-
arterial catheter. A Doppler flow device was used to measure 
the blood flow. The surgical procedure took approximately 3 
hours from initial incision to skin closure.  
Once the hydrogel had expanded to the blood vessel wall 
the delivery device was removed. Angiography was used 
(every ten minutes) following the procedure to visually 
validate the occlusion of the blood vessel. The sheep were 
monitored for side effects and sacrificed after 4 weeks in order 
to retrieve the ERH to investigate any signs of deterioration. 
III. RESULTS AND DISCUSSION 
A. Characterization of Electro-Responsive Hydrogel 
The PLMANa hydrogel swelling rates in Krebs solution and 
blood plasma are shown in Fig 4. The results show that the 
average swelling rate was similar for both solutions, which is 
expected since Krebs solution has a similar ionic 
concentration as blood plasma. The hydrogel samples had a 
swelling rate of 258% and 279% within 30 minutes for Krebs 
and blood plasma respectively. After 24 hours the samples in 
Krebs solution swelled 1540% on average compared to 1450% 
for blood plasma. The maximum swelling results show no 
significant difference between the two set of samples p>0.1. 
The results confirm that Krebs solution can be used as an 
alternative to blood plasma for in vitro testing, and that the 
PLMANa hydrogels swell significantly in physiological fluid. 
The swelling rate in whole blood is expected to be slightly 
slower due to the presence of proteins and other molecules. 
Free swelling hydrogels swell in all dimensions. However, in a 
blood vessel the hydrogel will begin to swell radially until it 
contacts the vessel wall and then it will begin to expand 
lengthwise until it reaches equilibrium. A higher final swelling 
value is desired as it allows the hydrogel to be smaller during 
insertion, but it would have the disadvantage of having 
reduced mechanical properties.  
 
Fig. 4.  Average swelling results versus time PLMANa in Krebs solution and 
Blood plasma. Error bars represent the standard deviation, and the line is a 
fitted model. 
 
The results for the in vitro electro-actuation experiment 
using the macro-scale IDT electrodes, were used to validate 
the deceleration of the hydrogel’s swelling due to an electrical 
bias is shown in figure 5. The results show that the electrically 
biased hydrogels did not expand as quickly as the non-biased 
hydrogels. A t-test showed that there was a significant 
difference between the two samples p<0.01. Swelling of a 
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polyelectrolyte hydrogel is governed by the osmotic pressure 
of the counter ions. The added salt ions from Krebs or blood 
plasma decelerate the process compared to pure water. 
Swelling stops when the chemical potential of ions inside the 
ERH and bulk solution are equal. The electrical bias causes 
the hydrogel to swell even slower, interfering with the 
diffusion of the ions until equilibrium is reached. Both sets of 
samples expand which was expected as the hydrogel still 
absorbs the fluid from the Krebs solution. The results also 
show that the difference in the expansion increases with time. 
The expansion rate of the ERH decreases as the hydrogels 
expand. This is related to the depth of the electric field. The 
dried samples were 3 mm in diameter where as the IDT 
electrodes have a configuration diameter of approximately 6 
mm. The depth of the electric-field from the IDT in this case 
was previously shown to be shallow [9]. As the hydrogel 
expands it becomes closer to the electrodes thus increasing the 
impact of the applied electrical bias. Based on these results an 
ideal IDT electrode would expand/shrink with the hydrogel, 
however this is difficult to achieve.  
 
Fig. 5.  Average swelling results versus time for electrically biased samples 
compared to non-biased (control) samples, the line is a fitted model, and error 
bars represent the standard deviation. 
 
Previous results demonstrated that an electrical bias does 
not significantly affect the swelling equilibrium level, as the 
ERH swells normally, once the biased is removed [9].The 
overall results from the in vitro electro-actuation experiment 
validate the concept that an IDT electrode configuration can 
slow down expansion of the hydrogel. Therefore, an IDT 
electrode configuration integrated into a delivery system could 
be used for operations that require longer insertion times. 
Another electrode configuration option includes using a 
peripheral electrode with a center core electrode (guide wire). 
However, the disadvantage to using a center core electrode is 
that a hole needs to be created in the hydrogel which prolongs 
the swelling rate to cause a full occlusion. 
 
Fig. 6.  Images of the hydrogel swelling in an ex vivo carotid artery. (a) 12 
minutes post implant, (b) 30 hours post implant (c) imaging showing bulging 
properties of the hydrogel. Arrows show location of the hydrogel and balloon 
of delivery device (big arrow). 
 
 The flexible IDT electrodes were validated for single use 
only, because the TiW layer developed micro-cracks when 
bent, which lead to the dissolution of the Au layer during an 
applied electrical bias due to its exposure to chloride ions in 
Krebs solution. There are methods to resolve this issue in the 
future, for instance:  i) an all Pt IDT electrode or ii) to 
electroplate a thick Pt layer after the flexible material has been 
bent. As mentioned in section II, the first option is expensive 
and difficult to fabricate since thick Pt is difficult to pattern. 
The latter option would protect the gold layer from dissolution 
by coating it with a crack-free Pt layer. 
B. Ex Vivo Results 
The image in Fig.6 shows swelling of the ERH at various 
time intervals. The results show that the ERH was able to 
occlude the ex vivo carotid artery of a sheep. In addition, a 
bulge in the artery is visually noticeable. The bulge helps to 
prevent the hydrogel from moving. Once the hydrogel 
swelling force cannot overcome the elastic properties of the 
blood vessel the hydrogel starts to expand laterally instead of 
radially, which can be seen from the expansion in length from 
Fig. 6a to Fig. 6b. 
 
 Table I shows the results from the ex vivo test for the three 
hydrogel samples. The carotid artery had an initial diameter of 
7.1 ± 0.5 mm. The fully swollen hydrogels had a diameter of 
7.6 ± 0.3, which shows that there was an average bulge 
increase of approximately 0.5 mm. This amount of bulge is 
not significant to cause long-term permanent damage to the 
blood vessel. The overall volume expansion of the hydrogel 
was 962 ± 50%. The average maximum pressure that the ERH 
were able to withstand before being dislodged was 243 ±25 
mmHg, which is higher than normal physiological blood 
pressure. However, the maximum pressure that the ERH could 
withstand is believed to be highly dependent on the length of 
the fully swollen hydrogel. Therefore, a longer material should 
be more difficult to dislodge. This is to be expected as the 
force required to dislodge the material is related to both the 
friction and the contact force which is dependent on the 
contact length. 
 
Fig.7. Angiography of occluded carotid artery 1 hour after delivery of 
hydrogel, the black arrow shows location of the hydrogel. 
C. In Vivo Results 
Results from the in vivo testing of the occluded carotid 
artery of sheep are shown in Fig. 7 and Table II. All four ERH 
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TABLE I 
Characteristics of Swollen Hydrogels in Ex Vivo Carotid Arteries 
 Diameter of 
Carotid 
Artery 
(mm) 
Length of 
Hydrogel 
fully 
Swollen 
(mm) 
Diameter of 
Hydrogel 
fully 
Swollen 
(mm) 
Volume 
Expansion 
(%) 
Maximum 
Pressure 
(mmHg) 
Gel 1 7.35 20.5 7.94 1003 220 
Gel 2 7.45 22.8 7.64 978 240 
Gel 3 6.47 29.3 7.25 906 >270 
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successfully occluded the carotid artery as shown in the 
angiography in Fig. 7. The average flow in the carotid artery 
before implantation of the hydrogel was 245 ± 7 ml/min, while 
after implantation the flow was 0 ml/min in all four sheep. The 
flow rate remained 0 ml/min throughout the duration of the 
experiment.  There was a slight pressure drop over the 
hydrogel due to collateral flow. 
 
The animals did not show any visual side effects in 
behavior due to the occlusion of the carotid artery, and no 
changes were seen on the CT scans. After the sheep were 
sacrificed the ERH implants were explanted to investigate the 
integrity of the implants and vessels. Figure 8 shows the 
explanted hydrogel. Visually, the ERH was intact and showed 
no signs of deterioration or cracking. The ERH did not adhere 
to the wall of the carotid artery. The swollen ERH had a 
diameter of 7.4 ± 1.1 mm and they had an initial diameter of 3 
mm. The ERH also swelled lengthwise once the hydrogel was 
in contact with the vessel wall. 
 
Fig. 8. Explanted carotid artery with occluded hydrogel. Black arrows show 
the location of the hydrogel. The thick black arrow shows a thrombus at the 
proximal site. 
IV. CONCLUSION 
This paper demonstrates the successful synthesis of an ERH 
and its ability to occlude a carotid artery both ex vivo and in 
vivo. The in vitro mechanical and electrical characterization of 
the ERH validates the concept of using an electrical bias to 
decelerate the expansion of the material. Removal of the 
electrical bias allowed the ERH to passively swell, which 
provided precise control over the timing of the ERH swelling.  
Ex vivo results of the carotid arteries showed that the ERH 
could withstand physiological blood pressures of >270 mmHg 
while maintaining an occlusion. In vivo experiments validated 
that the ERH could be delivered to the carotid artery and it 
created an occlusion, which prevented blood flow.  
 The delivery device that was developed allows for a 
minimal invasive implantation of an ERH to a blood vessel to 
create an occlusion. The delivery device had an integrated 
electrical connection that could be powered using a signal 
generator connected to the IDT electrode. The electrical bias 
applied to the ERH could be used to decelerate the expansion 
of the ERH in long duration surgical procedures.  
 Future work in this area will include optimization of the 
ERH material to increase the expansion rate and optimization 
of the electrode configuration and electrical bias parameters. 
In addition a complete biocompatibility experiment of the 
hydrogels and their interaction with the physiological 
environment will be conducted, along with long-term studies 
to determine the ERH stability. 
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